Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19
Fabio Fernandes Neves, Henrique Pott-Junior, Sigrid De Sousa Santos, Marcia Regina Cominetti, Caio Cesar De Melo Freire, Anderson Ferreira Da Cunha, Alceu Afonso Jordão Júnior
Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2022.05.027
Background & aims: Several studies have shown conflicting results for the relationship between vitamin D deficiency and COVID-19 outcomes. Here, we aimed to evaluate whether plasma 25(OH)D levels predict mortality in adults admitted with COVID-19, considering potential confounders. Methods: We conducted a retrospective cohort study that included 115 adults (age 62.1 ± 17.6 years, 65 males) admitted to a Brazilian public hospital for severely symptomatic COVID-19. Subjects were classified into two groups according to their plasma levels of 25(OH)D: sufficiency (50 nmol/L) and the deficiency (<50 nmol/L). The diagnosis of COVID-19 was performed using real-time polymerase chain reaction (qPCR). In addition, direct competitive chemiluminescence immunoassay assessed serum 25(OH)D levels. Results: The all-cause 30-day mortality was 13.8% (95% CI: 6.5%e21%) in the group of patients with sufficient plasma 25(OH)D levels and 32.1% (95% CI: 14.8%e49.4%) among those with deficient plasma 25(OH)D levels. Cox regression showed that plasma 25(OH)D levels remained a significant predictor of mortality even after adjusting for the covariates sex, age, length of the delay between symptom onset and hospitalization, and disease severity (HR ¼ 0.98, 95% CI: 0.96e1.00; p ¼ 0.02). Conclusion: Vitamin D deficiency predicts higher mortality risk in adults with COVID-19.
Author contributions Conceptualization, F.F.N. and H.P-J.; data curation, F.F.N., H.P-J. and S.S.S; formal analysis, F.F.N. and H.P-J.; funding acquisition, F.F.N.; investigation, F.F.N., H.P-J. and S.S.S; methodology, F.F.N., H.P-J., C.C.M.F, A.F.C. and A.A.J-J; resources, M.R.C., C.C.M.F, A.F.C. and A.A.J-J; software, H.P-J.; supervision, F.F.N. and H.P-J.; writing original draft, F.F.N. and H.P-J.; final approval: all authors.
Declaration of competing interest The authors declare no conflicts of interest.
Appendix A. Supplementary data Supplementary data to this article can be found online at https://doi.org/10.1016/j.clnesp.2022.05.027.
References
Akbar, Wibowo, Pranata, Setiabudiawan, Low serum 25-hydroxyvitamin D (vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis, Front Nutr
Ali, Role of vitamin D in preventing of COVID-19 infection, progression and severity, J Infect Public Health
Banerjee, Ganguly, Saha, Chakrabarti, Saini et al., Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits, Expert Rev Anti Infect Ther
Bui, Zhu, Hawkins, Cortez-Resendiz, Bellon, Vitamin D regulation of the immune system and its implications for COVID-19: a mini review, SAGE Open Med
Dissanayake, Silva, Sumanatilleke, De Silva, Gamage et al., Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis, J Clin Endocrinol Metab
Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley et al., Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet Lond Engl
Neves, Pott-Junior, De Sousa Santos, None, Clinical Nutrition ESPEN
Neves, Pott-Junior, De Sousa Santos, None, Clinical Nutrition ESPEN
Tay, Poh, Macary, Ng, The trinity of COVID-19: immunity, inflammation and intervention, Nat Rev Immunol
Tentolouris, Samakidou, Eleftheriadou, Tentolouris, Jude, The effect of vitamin D supplementation on mortality and Intensive Care Unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression, Diabetes Metab Res Rev
Yisak, Ewunetei, Kefale, Mamuye, Teshome et al., Effects of vitamin D on COVID-19 infection and prognosis: a systematic review, Risk Manag Healthc Pol